Finance

Lists
Outlook: 39.1% bullish·13.0% bearish
Go to analysis
ANGO:NASDAQ
AngioDynamics, Inc.
US$ ११.०५
+१.३८%
(+०.१५) 1D
US$ १०.७९
-२.३७% (-०.२६)
After hours
Closed: अक्टोबर १४, १६:००:०१ GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ANGO...
Open
US$ १०.७९
High
US$ ११.४८
Low
US$ १०.७३
Mkt. cap
४६.४७ करोड
Avg. vol.
७.४४ लाख
Volume
१५.९० लाख
52-wk high
US$ १६.२९
52-wk low
US$ ९.३९
EPS
-US$ ०.८८
Beta
०.३०
Shares outstanding
४.२१ करोड
No. of employees
६३२
Open
US$ १०.७९
High
US$ ११.४८
Low
US$ १०.७३
Mkt. cap
४६.४७ करोड
Avg. vol.
७.४४ लाख
Volume
१५.९० लाख
52-wk high
US$ १६.२९
52-wk low
US$ ९.३९
EPS
-US$ ०.८८
Beta
०.३०
Shares outstanding
४.२१ करोड
No. of employees
६३२
News stories
From web sources and news partners
About AngioDynamics, Inc.
CEOJames Clemmer
Employees६३२
Founded१९८८ फेब्रुअरी ९
Headquarters-
Sector-
Websiteangiodynamics.com
Analyst ratings
Based on 2 analysts giving stock ratings to ANGO in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for ANGO in the last 3 months.
Highest
Current US$ ११.०५
US$ २०.०० (+८१.००%)
Average
US$ १९.०० (+७१.९५%)
Lowest
US$ १८.०० (+६२.९०%)
Analyst
Recommendation
Action
Price target
Projected
Date
Yi Chen
H.C. Wainwright
Buy
Reiterated
US$ १८.००
+६२.९%
10/14/2026
John Young CFA
Canaccord Genuity
Buy
Reiterated
US$ २०.००
+८१%
10/09/2026
Frank Takkinen
Lake Street
Buy
Maintained
US$ २४.००
+११७.२%
07/14/2026
Ilya Zubkov
Freedom Capital Markets
Buy
Initiated
US$ १६.००
+४४.८%
04/06/2026
Last report
२०२६ अक्टोबर ८
Fiscal period
Q1 2027
-US$ ०.०४ / -US$ ०.११
+६४.७०%beat
Revenue / Est. (USD)
८.०९ करोड / ८.०५ करोड
+०.५२%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ नोभेम्बर
२०२६ फेब्रुअरी
२०२६ मे
२०२६ अगस्ट
Revenue
७.९४ करोड
७.८४ करोड
८.६६ करोड
८.०९ करोड
Cost of goods sold
३.४६ करोड
३.६९ करोड
३.९८ करोड
३.४१ करोड
Cost of revenue
३.४६ करोड
३.६९ करोड
३.९८ करोड
३.४१ करोड
Research and development expenses
७६.३३ लाख
६९.३३ लाख
८०.३४ लाख
७८.२५ लाख
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
३.७० करोड
३.८३ करोड
४.१५ करोड
४.२६ करोड
Operating expense
४.७३ करोड
४.७९ करोड
५.२४ करोड
५.३२ करोड
Total operating expenses
८.१९ करोड
८.४९ करोड
९.२३ करोड
८.७२ करोड
Operating income
-२४.९० लाख
-६४.२९ लाख
-५६.५० लाख
-६३.२१ लाख
Other non operating income
-१.२८ लाख
४९.६७ लाख
-७.३५ लाख
९४.०० हजार
EBT including unusual items
-६३.५५ लाख
-८०.७२ लाख
-१.१० करोड
-७२.९६ लाख
EBT excluding unusual items
-२७.२० लाख
-१५.५० लाख
-६४.९० लाख
-६३.१५ लाख
Income tax expense
-५.०० हजार
१२.०० हजार
३.७० लाख
-१.९९ लाख
Effective tax rate
०.०८%
-०.१५%
-३.३५%
२.७३%
Other operating expenses
-
-
१.३८ लाख
-
Net income
-६३.५० लाख
-८०.८४ लाख
-१.१४ करोड
-७०.९७ लाख
Net profit margin
-७.९९%
-१०.३१%
-१३.१७%
-८.७७%
Earnings per share
-
०.०२
-०.०७
-०.०४
Interest and investment income
-
१२.०० हजार
१.०० हजार
-
Interest expense
-१.०२ लाख
-१.०० लाख
-१.०६ लाख
-८८.०० हजार
Net interest expenses
-१.०२ लाख
-८८.०० हजार
-१.०५ लाख
-८८.०० हजार
Depreciation and amortization charges
-
-
-
-
EBITDA
३२.५७ लाख
-८.३८ लाख
-३.५३ लाख
-८.२३ लाख
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google एपहरू